| Name | Title | Contact Details |
|---|
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.
Coloplast is among the world’s leading suppliers of intimate healthcare products and services. As a group, we have built our current position by listening to consumers and understanding their needs. For more than 50 years, Coloplast has developed and marketed innovative products that make life easier for people with diseases of a personal and private nature. Our focus is centered on ostomy care, continence care, urology care and skin and wound care.
Alva Amco Pharmacal Companies, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Niles, IL. To find more information about Alva Amco Pharmacal Companies, Inc., please visit www.alva-amco.com
PlayMaker Health`s post-acute software transforms provider claims into actionable business intelligence. Integrating within existing industry workflows, the platform, and mobile-first CRM unify market and sales performance data, delivering the actionable analytics and business intelligence post-acute providers need to accelerate growth and expand competitive market share.
Modern Concepts Medical is a Montebello, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.